Biondo Investment Advisors, LLC Moderna, Inc. Transaction History

Biondo Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $185,782 - $243,977	1,927 Added 7.65%	27,105 $2.8 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $56,643 - $76,733	478 Added 1.94%	25,178 $3.06 Million
Q1 2023 May 09, 2023	BUY	$135.66 - $197.02 $69,864 - $101,465	515 Added 2.13%	24,700 $3.79 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $15,862 - $28,145	-134 Reduced 0.55%	24,185 $4.34 Million
Q3 2022 Nov 07, 2022	BUY	$118.07 - $194.18 $91,740 - $150,877	777 Added 3.3%	24,319 $2.88 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $38,652 - $58,274	330 Added 1.42%	23,542 $3.36 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $150,487 - $279,709	-1,190 Reduced 4.88%	23,212 $4 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $10,613 - $17,319	47 Added 0.19%	24,402 $6.2 Million
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $13,314 - $29,068	60 Added 0.25%	24,355 $9.37 Million
Q2 2021 Aug 03, 2021	BUY	$129.91 - $234.98 $3.16 Million - $5.71 Million	24,295 New	24,295 $5.71 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Biondo Investment Advisors, LLC with notifications on news.